Friday, May 28, 2021 3:02:36 PM
According to the CDC 438 individuals died from Covid last week in the US. 50% of the population is vaccinated,but the vaccination rates are dropping sharply. Tens of thousands are dying abroad.
https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html
I think the Remdeivir model and timeline still applies since another Covid antiviral has not been approved and additional experience with Remdesivir has not confirmed the early enthusiasm.
Remdesivir was given on a compassionate use basis at the very beginning of the US infections in January 2020. This is before any of the clinical trials were finished, but based on studies done for Ebola, SARS and MERs.
https://www.nejm.org/doi/full/10.1056/NEJMoa2007016
In March of 2020 Gilead began an expanded compassionate use program. The first Redesivir Covid 19 trial was begun in China , but suspended. The adaptive phase 2-3 trial was begun on 2/21/2020 and first results posted on 9/25/2020
EUA was granted on May 1,2020 and approval by the FDA was given on 10/25/2020.
IMO that gives a timeline on how Brilacidin may progress.
If the phase 2 Brilacidin trial is very positive. I believe expanded compassionate use could be begin soon. To be quickly followed by an announcement of a phase 3 study with grants and possible partnership. If the phase 3 study shows promise at the first interim report we could see an EUA. Formal FDA approval would be given after the phase 3 trial is completed.
If the phase 2 trial shows modest results, ie better than Remdesivir, we could still see the course accelerated.
Time will tell.
Good luck to all,
Farrell
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM